Explore how emerging market bonds deliver high yields and growth with Western Asset Emerging Markets Debt Fund Inc. Click for ...
EMD's 10.7% yield is attractive, but payout sustainability is questionable as distributions often exceed net investment ...
ROCKLAND, MA, April 7, 2014 /CNW/ - EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, today announced the initiation of the international Phase III START2 study, which is designed to ...
• START2 builds upon the data from the START* trial and explores the potential of tecemotide in patients with Stage III NSCLC who have demonstrated stable disease or objective response after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results